Tumor necrosis factor-alpha, sphingomyelinase and ceramides activate tyrosine kinase, p21Ras and phosphatidylinositol 3-kinase: implications for glucose transport and insulin resistance

Adv Exp Med Biol. 2001:498:191-200. doi: 10.1007/978-1-4615-1321-6_25.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Transport
  • Ceramides / pharmacology*
  • Enzyme Activation
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Glucose / metabolism*
  • Insulin Resistance / physiology*
  • Kinetics
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Protein-Tyrosine Kinases / metabolism*
  • Proto-Oncogene Proteins p21(ras) / metabolism
  • Rats
  • Sphingomyelin Phosphodiesterase / pharmacology*
  • Sphingosine / analogs & derivatives*
  • Sphingosine / pharmacology
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Ceramides
  • N-acetylsphingosine
  • Tumor Necrosis Factor-alpha
  • Phosphatidylinositol 3-Kinases
  • Protein-Tyrosine Kinases
  • Sphingomyelin Phosphodiesterase
  • Proto-Oncogene Proteins p21(ras)
  • Glucose
  • Sphingosine